- SLC22A17/LCN2 are higher in glioma tissues but rarely present in non-neoplastic brain tissues (RNA and protein)- Overexpression of SLC22A17/LCN2 in glioma patients correlate with poor prognosis and low survival. Here, SLC22A17 is linked to central nervous system cancer.